Related Experiment Video
Updated: Jul 3, 2026

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Hemoglobin target in chronic kidney disease: a pediatric perspective
Pediatric Nephrology (Berlin, Germany)
|July 8, 2008
Summary
Erythropoietin therapy improves quality of life for anemic children with chronic kidney disease (CKD). However, optimal hemoglobin targets for pediatric CKD patients remain uncertain, questioning adult study applicability.
Area of Science:
- Pediatric Nephrology
- Hematology
- Anemia Management
Background:
- Anemia is prevalent in children with chronic kidney disease (CKD), affecting up to 93.3% in advanced stages.
- Erythropoietin (EPO) has improved quality of life and reduced transfusions in anemic pediatric CKD patients.
- Defining anemia in children (ages 1-19) involves specific hemoglobin (Hgb) level thresholds based on sex and age.
Discussion:
- Recent adult CKD trials on optimal hemoglobin levels create uncertainty for pediatric treatment targets.
- Generalizing adult study findings to pediatric CKD patients is questionable due to physiological differences.
- Lack of adequately powered, randomized controlled trials in children hinders evidence-based guideline development.
Key Insights:
- The benefit of normalizing anemia in pediatric CKD requires critical evaluation.
- Current Food and Drug Administration (FDA) guidance offers limited specific targets for pediatric Hgb levels.
- The appropriateness of applying adult EPO treatment protocols to children with CKD is under scrutiny.
Outlook:
- Further research is needed to establish optimal hemoglobin targets for anemic children with CKD.
- Development of pediatric-specific guidelines for erythropoietin therapy is essential.
- Clarifying the long-term benefits and risks of anemia normalization in pediatric CKD is a priority.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...